Observational Study on Contraception With Essure in France

NCT ID: NCT02510443

Last Updated: 2017-09-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

2644 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-06-23

Study Completion Date

2016-11-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Using a very broad survey, the objective is to confirm the effectiveness of the Essure method, and to obtain more information on the conditions of use as well as on the methods used during the 3-month check-up, as well as the 12-month, 24-month and 5-year follow-up on patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study is a prospective epidemiological survey to collect local real life data on patients under routine pratice

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Contraception

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

BAY1454032

All subjects who give their consent and meet the eligibility criteria will be scheduled for an insert placement procedure

ESS305 (Essure, BAY1454032)

Intervention Type DEVICE

Bilateral insert placement

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ESS305 (Essure, BAY1454032)

Bilateral insert placement

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Woman ≥ 18 years old,
* Scheduled for Essure procedure
* Patient who has been given appropriate information about the study objectives and procedures and who has given her consent.

Exclusion Criteria

* Patients with contraindications as listed in the current Instruction For Use (IFU) will be excluded.
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hôpital André Mignot Centre Hospitalier de Versailles

UNKNOWN

Sponsor Role collaborator

Bayer

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bayer Study Director

Role: STUDY_DIRECTOR

Bayer

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Le Chesnay, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ES0810FR

Identifier Type: OTHER

Identifier Source: secondary_id

18097

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

ESS505 Pre-hysterectomy Protocol
NCT01664052 COMPLETED NA
European Active Surveillance Study of LCS12
NCT02146950 ACTIVE_NOT_RECRUITING